|Articles|May 1, 2013
- Pharmaceutical Executive-05-01-2013
- Volume 0
- Issue 0
PE, May 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
over 12 years ago
Is That VBP on the Horizon, or a Mirage?over 12 years ago
Country Report: Austriaover 12 years ago
The Friendly Persuasion — An Interview with Fred Hassanover 12 years ago
Whistling Past the Graveyardover 12 years ago
The Patent Black Labelover 12 years ago
It's Time For a Code of Ethics in Patient Educationover 12 years ago
The Health Information Advantageover 12 years ago
Generic Drug Gains and GrumblesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
